ArticleFrontiers in nutrition2025
Temporal trends and geographic disparities in thyroid cancer burden: a global analysis from 1990 to 2021.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- PKM2-Mediated Glycolytic Reprogramming in Thyroid Cancer: Mechanistic Insights and Therapeutic Potential.Molecules (Basel, Switzerland) · 2026Review
- Impact of UGT1A9 Expression on Analgesic Efficacy and Safety of Postoperative Ketorolac in Thyroid Cancer Surgery: A Prospective Cohort Study.Journal of pain research · 2026Article
- Advances in immunotherapy for thyroid malignancies: from molecular targets to clinical outcomes.Frontiers in medicine · 2026Review
- Global burden of thyroid cancer in males: a comprehensive analysis of incidence, mortality, and risk factors from 1990 to 2040.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Over the past 40 years, the global incidence of thyroid cancer has increased steadily. This study aimed to update the evaluation of thyroid cancer prevalence, incidence, mortality, and Disability-Adjusted Life Years (DALYs) rates from 1990 to 2021, with a focus on integrating prevalence data. Analyses were stratified by gender, age, and Socio-Demographic Index (SDI) at global, regional, and national levels. Methods: Data were obtained from the 2021 Global Burden of Disease, Injuries, and Risk Factors Study (GBD). The estimated annual percentage change (EAPC) was calculated to quantify temporal trends and evaluate age - standardized rates for prevalence (ASPR), incidence (ASIR), mortality (ASDR), and DALYs. Results: In 2021, the global thyroid cancer burden was substantial, with 1,987,148.5 cases. From 1990 to 2021, the ASPR increased from 14.9 (95% Uncertainty Interval [UI]: 14.1-16.0) to 23.1 (95% UI: 20.7-25.6) per 100,000 population, with an EAPC of 1.58 (95% UI: 1.44-1.73); the ASIR increased from 2.1 (95% UI: 2-2.2) to 2.9 (95% UI: 2.6-3.2) per 100,000 population, with an EAPC of 1.25 (95% UI: 1.14-1.37); the ASDR declined from 0.6 (95% UI: 0.5-0.6) to 0.5 (95% UI: 0.5-0.6) per 100,000 population, with an EAPC of -0.24 (95% UI: -0.24 - -0.21); the age - standardized DALY rate decreased from 15.2 (95% UI: 14.2-16.8) to 14.6 (95% UI: 12.8-16.1) per 100,000 population, with an EAPC of -0.14 (95% UI: -0.17 - -0.11). Western Sub-Saharan Africa had the lowest rates, while high-income North America had the highest ASPR and ASIR, and Andean Latin America had the highest ASDR. Higher SDI regions showed higher ASPR and ASIR, whereas lower SDI regions had higher ASDR. Saudi Arabia had the highest ASPR and ASIR, and Ethiopia had the highest ASDR and age-standardized DALY rate. Conclusion: From 1990 to 2021, the global health burden of thyroid cancer increased significantly, with marked geographical disparities. Prevention and control strategies should consider the unequal global distribution of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.